RSS Feeds
Cryptogenic Stroke and Patent Foramen Ovale
- Robert G. Holloway, Jr., MD, MPH; and
- Ralph F. Józefowicz, MD
- From University of Rochester School of Medicine, Rochester, NY 14642.
IN RESPONSE:
In our article, we do state that “warfarin therapy is generally not indicated for secondary stroke prevention except for patients with transient ischemic attack or stroke in the setting of persistent or paroxysmal atrial fibrillation and for some patients with a documented hypercoagulable state, left ventricular ejection fraction of 0.3 or less, …
This 100-word excerpt has been provided in the absence of an abstract.
